Evidence map›Paper›PMID 18363420›Full record

Trial reportThe Journal of clinical psychiatry2008

Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.

Kimberly A Yonkers, Haiqun Lin, Heather B Howell, A Christopher Heath, Lee S Cohen

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical psychiatry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 7 pooled it
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 7 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Antidepressant treatment for postnatal depression.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Pooled it
  5. Antidepressants for preventing postnatal depression.The Cochrane database of systematic reviews · 2018
    Pooled it
  6. Antidepressant treatment for postnatal depression.The Cochrane database of systematic reviews · 2014
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Comparative Efficacy of Interventions for the Prevention and Treatment of Postpartum Depression: A Bayesian Network Meta-analysis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kimberly A YonkersDepartment of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA. Kimberly.Yonkers@yale.edu
Haiqun Lin
Heather B Howell
A Christopher Heath
Lee S Cohen
Yale University · USHarvard University Press · US

Funding

DETECTION AND TREATMENT OF POSTPARTUM DEPRESSIONK08MH001908 · NIMH · YALE UNIVERSITY · PI YONKERS, KIMBERLY A · 1999 to 2003
$633k
Assessing Intervention Effectiveness in Longitudinal Trials of Antipsychotic MediR21MH080959 · NIMH · YALE UNIVERSITY · PI LIN, HAIQUN · 2008 to 2009
$390k
NIMH NIH HHS K08 MH001908NIMH NIH HHS MH01648NIMH NIH HHS R21 MH080959
6 · The paper itself

Abstract

objectiveApproximately 6% to 8% of postpartum women suffer from major depressive disorder (MDD), but only a few controlled trials have investigated the efficacy of pharmacologic treatments. The current study determined the relative efficacy of paroxetine compared to placebo in the treatment of acute postpartum MDD.

methodThis was an 8-week, multicenter, parallel, placebo-controlled trial of paroxetine for treatment of postpartum depression. Subjects were eligible if they had an onset of DSM-IV MDD after, but within 3 months of, delivery and had a minimum score of 16 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) at intake. Seventy women were randomly assigned to either immediate-release paroxetine or matching placebo, and 31 completed the trial. Subjects were reassessed with the HAM-D-17, the Inventory of Depressive Symptomatology-Self-Report (IDS-SR) form and the Clinical Global Impressions (CGI) scales. The study was conducted between 1997 and 2004.

resultsBoth groups improved over time and did not differ significantly on the HAM-D-17 or IDS-SR at follow-up. However, greater improvement in overall mean +/- SD clinical severity was found for the paroxetine (Clinical Global Impressions-Severity of Illness [CGI-S] score = 1.8 +/- 1.4) compared with the control group (CGI-S score = 3.1 +/- 1.4; p = .05). The paroxetine group also had a significantly higher rate of remission, compared to the placebo group (37% vs. 15%, odds ratio = 3.5, 95% CI = 1.1 to 11.5). The rate of adverse effects did not differ significantly between groups.

conclusionStudy results were limited by lower than expected enrollment and higher than anticipated attrition. Nonetheless, paroxetine treatment was associated with a significantly higher rate of remission among women with postpartum onset of MDD.

Indexed as

AdultBreast FeedingDemographyDepression, PostpartumDiagnostic and Statistical Manual of Mental DisordersFemaleHumansMajor Depressive DisorderParoxetineSelective Serotonin Reuptake InhibitorsSurveys and QuestionnairesParoxetineSelective Serotonin Reuptake Inhibitors

Identifiers

PMID18363420
PMCPMC3073141
OpenAlexW2016972223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.